Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain.
Alonso Torres AM, Arévalo Bernabé AG, Becerril Ríos N, Hellín Gil MF, Martínez Sesmero JM, Meca Lallana V, Ramió-Torrentà L, Rodríguez-Antigüedad A, Gómez Maldonado L, Triana Junco I, Gómez-Barrera M, Espinoza Cámac N, Oyagüez I.
Alonso Torres AM, et al. Among authors: gomez barrera m.
Pharmacoecon Open. 2023 May;7(3):431-441. doi: 10.1007/s41669-023-00394-2. Epub 2023 Feb 21.
Pharmacoecon Open. 2023.
PMID: 36802327
Free PMC article.